- Report
- June 2026
- 140 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- May 2026
- 350 Pages
Global
From €4632EUR$4,949USD£3,872GBP
- Report
- January 2026
- 150 Pages
Global
From €3697EUR$3,950USD£3,090GBP
- Report
- August 2026
- 160 Pages
Global
From €3107EUR$3,320USD£2,597GBP
€3884EUR$4,150USD£3,247GBP
- Report
- September 2026
- 199 Pages
Global
From €3318EUR$3,545USD£2,773GBP
€3687EUR$3,939USD£3,082GBP
- Report
- September 2026
- 193 Pages
Global
From €3318EUR$3,545USD£2,773GBP
€3687EUR$3,939USD£3,082GBP
- Report
- September 2026
- 198 Pages
Global
From €3318EUR$3,545USD£2,773GBP
€3687EUR$3,939USD£3,082GBP
- Report
- September 2026
- 191 Pages
Global
From €3318EUR$3,545USD£2,773GBP
€3687EUR$3,939USD£3,082GBP
- Report
- September 2026
- 189 Pages
Global
From €3318EUR$3,545USD£2,773GBP
€3687EUR$3,939USD£3,082GBP
- Report
- November 2026
- 281 Pages
Global
From €5475EUR$5,850USD£4,577GBP
- Report
- November 2026
- 364 Pages
Global
From €5475EUR$5,850USD£4,577GBP
- Report
- February 2026
- 250 Pages
Global
From €4202EUR$4,490USD£3,513GBP
- Report
- May 2026
- 180 Pages
Global
From €4212EUR$4,500USD£3,520GBP
- Clinical Trials
- May 2026
- 80 Pages
Global
From €1872EUR$2,000USD£1,565GBP
- Report
- August 2026
- 112 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- May 2026
- 200 Pages
Global
From €2610EUR$2,789USD£2,182GBP
- Report
- March 2026
- 200 Pages
Global
From €2610EUR$2,789USD£2,182GBP
- Report
- January 2026
- 148 Pages
Global
From €3697EUR$3,950USD£3,090GBP
- Report
- August 2026
- 160 Pages
Global
From €3107EUR$3,320USD£2,597GBP
€3884EUR$4,150USD£3,247GBP
- Report
- August 2026
- 160 Pages
Global
From €3107EUR$3,320USD£2,597GBP
€3884EUR$4,150USD£3,247GBP

Opioid Use Disorder (OUD) is a type of addiction disorder that is characterized by the compulsive use of opioids, such as heroin, morphine, and prescription painkillers. OUD is a serious public health issue, with an estimated 2.1 million people in the United States suffering from the disorder. OUD is associated with a range of physical and psychological health problems, including an increased risk of overdose, infectious diseases, and mental health issues. Treatment for OUD typically involves a combination of medication-assisted treatment (MAT) and psychosocial interventions. MAT involves the use of medications, such as buprenorphine and methadone, to reduce cravings and withdrawal symptoms. Psychosocial interventions include cognitive-behavioral therapy, motivational interviewing, and 12-step programs.
Companies in the OUD market include Indivior, Alkermes, Orexo, and Braeburn Pharmaceuticals. Show Less Read more